Related Experiment Video
Updated: Jan 19, 2026
07:28
Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System
Published on: April 6, 2017
41.4K
Inhaled Corticosteroids in Asthma and the Risk of Pneumonia
Min Hye Kim1, Chin Kook Rhee2, Ji Su Shim1
1Department of Internal Medicine, College of Medicine, Ewha Womans University, Seoul, Korea.
Allergy, Asthma & Immunology Research
|September 26, 2019
Summary
Inhaled corticosteroids (ICS) may increase pneumonia risk in asthma patients. This study highlights the need for careful monitoring of ICS use in individuals with asthma to mitigate potential complications.
Area of Science:
- Pulmonology
- Clinical Epidemiology
- Pharmacovigilance
Background:
- Asthma is a prevalent respiratory condition requiring long-term management, often with inhaled corticosteroids (ICS).
- The association between ICS use and increased pneumonia risk in asthma patients remains a subject of ongoing debate and investigation.
- Understanding this risk is crucial for optimizing asthma treatment strategies and patient safety.
Purpose of the Study:
- To investigate the potential association between inhaled corticosteroid (ICS) use and the incidence of pneumonia in a large cohort of asthma patients.
- To evaluate the risk of pneumonia in asthmatic individuals undergoing long-term treatment with ICS.
- To provide evidence-based insights for the clinical management of asthma and its associated complications.
Main Methods:
- Utilized the Health Insurance Review and Assessment Service (HIRA) database from Korea, encompassing 831,613 asthma patients.
- Analyzed patient demographics, comorbidities, healthcare utilization (outpatient visits, emergency department use, hospitalizations), and medication data.
- Employed multiple logistic regression analysis to determine the association between ICS prescription and pneumonia, adjusting for relevant covariates.
Main Results:
- Patients using ICS were older, had more comorbidities, and exhibited higher healthcare utilization compared to non-ICS users.
- A statistically significant association was found between ICS prescription and pneumonia (odds ratio, 1.38; 95% CI, 1.36-1.41).
- Factors such as age, sex, type of medical facility, and prior asthma-related hospitalization also correlated with pneumonia risk.
Conclusions:
- Inhaled corticosteroid (ICS) use is associated with an increased risk of pneumonia in asthma patients within the Korean healthcare setting.
- Clinicians should be aware of this potential risk and meticulously monitor asthmatic patients using ICS for signs of pneumonia.
- This finding underscores the importance of risk-benefit assessment and vigilant surveillance in long-term asthma management.
Related Concept Videos
01:25Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
1.5K
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
1.5K
01:26COPD: Management Using Bronchodilators and Corticosteroids
741
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
741
01:23Inhaled Medications
756
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
756
01:30Pneumonia I: Introduction
749
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
749
01:17Drugs Used in Lower Respiratory Disorders: Overview
1.1K
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
1.1K
01:20Asthma: Pathogenesis and Management
1.2K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.2K